A Legislative Yuan committee yesterday passed a motion asking Academia Sinica President Wong Chi-huey (翁啟惠) to resign amid a snowballing insider-trading scandal, while Wong said he might have indirectly invested in OBI Pharma Inc (台灣浩鼎), the company at the heart of the scandal.
Legislators across party lines passed the motion at a meeting of the Education and Culture Committee, which Wong attended.
The lawmakers said the scandal has done irreparable harm to Academia Sinica and the nation’s biotechnology industry, and Wong is no longer suitable to head the institute because he has failed to clarify his actions and is suspected of corruption and breach of trust.
Photo: Liu Hsin-de, Taipei Times
Wong should resign and cooperate with a prosecutors’ investigation, the motion states.
Wong tendered his resignation to President Ma Ying-jeou (馬英九) last month, citing health reasons, but Ma rejected it. He later decided to stay on in the post despite repeated calls for him to step down. On Tuesday, Ma denied Wong’s request for a 28-day leave of absence.
The controversy began after Wong endorsed OBI Pharma’s new cancer drugs, despite discouraging clinical trial results in February, and it emerged shortly afterward that his daughter is a major shareholder in the company. It also emerged that Wong, on behalf of his daughter, sold 10,000 of the firm’s shares before the trial results were publicly released.
Responding to Democratic Progressive Party Legislator Rosalia Wu’s (吳思瑤) question as to why he chose to stay in its post, thereby angering the public, Wong said: “I think the accusation is unfair to me. My resignation would not prove my innocence. I have to uphold Academia Sinica’s reputation, not mine. Many reports are unfair to me, so I have to remain in the post.”
Asked by Chinese Nationalist Party (KMT) Legislator Apollo Chen (陳學聖) if he held shares in OBI Pharma under other people’s names, Wong said he and OBI Pharma chairman Michael Chang (張念慈) had a joint investment fund, which was used to invest in two companies that later bought OBI Pharma shares.
“I gave the money to Chang, and he was in charge of the investment. I knew the two companies he invested in, which are not OBI Pharma. However, I realized later that the two companies had invested in OBI Pharma during the [prosecutors’] investigation,” he said.
While acknowledging Wong’s honesty, Chen said prosecutors should decide whether that investment violated the law.
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source